SkinBioTherapeutics (5KW) AI Stock Analysis

SkinBioTherapeutics

(Frankfurt:5KW)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong revenue growthSustained double-digit revenue expansion indicates product-market fit and accelerating commercial traction. Over 2-6 months this supports scale economics, strengthens partner bargaining, and provides a foundation to invest in R&D and commercialization even if profitability lags.

Negative Factors

Ongoing unprofitabilityPersistent negative net income and EBIT margins reduce internal funding for growth and force reliance on external capital. Without durable margin improvement, profitability risk can limit reinvestment, constrain strategic flexibility, and pressure valuation over multiple quarters.

SkinBioTherapeutics (5KW) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 13.61M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -29.2
Beta (1Y): -0.01
Revenue Growth: 93.15%
EPS Growth: 86.49%
Country: Germany
Employees: 41
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

SkinBioTherapeutics Business Overview & Revenue Model

Company Description

SkinBioTherapeutics Plc is a life sciences enterprise dedicated to enhancing human health through the exploration and development of technologies that harness the power of the human microbiome. The company has developed two primary technological plat...

SkinBioTherapeutics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:5KW against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:OBI	44Neutral	GBP 64.47M	-2.70	-9999.00%	―	26.99%	4.36%
GB:IMM	43Neutral	GBP 20.28M	-2.65	-559.87%	―	―	5.62%
GB:AREC	41Neutral	GBP 37.37M	165.00	3.75%	―	―	―
GB:OPTI	41Neutral	GBP 5.99M	-1.40	-77.85%	―	11.90%	-2864.29%
GB:APTA	37Underperform	GBP 10.23M	-9.50	-46.61%	―	28.35%	57.14%

* Healthcare Sector Average

Performance Comparison

DE:5KW and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:5KW	SkinBioTherapeutics plc	0.04	-0.12	-73.33%
GB:IMM	ImmuPharma plc	3.31	-6.69	-66.85%
GB:OPTI	OptiBiotix Health	5.80	-1.95	-25.16%
GB:AREC	Arecor Therapeutics PLC	82.50	10.00	13.79%
GB:APTA	Aptamer Group Plc	0.28	-0.53	-65.24%
GB:OBI	Ondine Biomedical, Inc.	9.30	-3.70	-28.46%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

SkinBioTherapeutics AI Stock Analysis